Showing results (2121-2130 of 2,286) with videos related to

Sort By:
Pageof 229
Microbiome|September 2, 2019
Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acidsShuai Wang, Rene Martins, Megan C Sullivan, et al.
Psychiatry Research|September 9, 2021
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-responseOle Köhler-Forsberg, Kirstine H Sloth, Louisa G Sylvia, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 22, 2023
Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel DiseaseJohanna M S Lemons, Maire Conrad, Ceylan Tanes, et al.
The New England Journal of Medicine|June 27, 2018
Recurrent Glioblastoma Treated with Recombinant PoliovirusAnnick Desjardins, Matthias Gromeier, James E Herndon, et al.
Plos One|March 3, 2012
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastomaJohn H Sampson, Robert J Schmittling, Gary E Archer, et al.
Molecular Cancer Therapeutics|January 20, 2005
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibitionRanjit K Goudar, Qing Shi, Mark D Hjelmeland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 4, 2014
The role of donor-specific HLA alloantibodies in liver transplantationJ G O'Leary, A J Demetris, L S Friedman, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
Cancer|October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
Early Intervention in Psychiatry|August 24, 2021
Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trialDavid J Miklowitz, Jean M Addington, Mary P O'Brien, et al.
Pageof 229